Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Mineralys Therapeutics, Inc. | StockGist | StockGist

Companies
MLYS
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings MLYSSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Mineralys Therapeutics, Inc.

Filed Feb 13, 2026

Accepted Feb 12, 2026, 7:00 PM ET

CIK 0001933414

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

79,139,956

Reporting Person

Mineralys Therapeutics, Inc.

Person Type

PN

CUSIP: 603170101

Amendment History

5 filings

SCHEDULE 13G
Original
Feb 5, 20260000315066-26-000484
SCHEDULE 13G/A
Amendment 1
Feb 14, 20250001104659-25-013268
SCHEDULE 13G/A
Amendment 2
Aug 14, 20250000950170-25-108851
SCHEDULE 13G/A
Amendment 3
Aug 14, 20250001415889-25-021836
SCHEDULE 13G/A
Amendment 4
Latest
Viewing
Feb 13, 20260001193125-26-051549

Key Facts

Shares Owned

79,139,956

Recent Filings

Mineralys Therapeutics, Inc.3 weeks ago

Mineralys Therapeutics, Inc.3 weeks ago

Mineralys Therapeutics, Inc.3 weeks ago

Mineralys Therapeutics, Inc.1 months ago

Mineralys Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice